KKSHL.BO · BSE
KK Shah Hospitals Limited
₹45
+0.00% (₹0)
Prev. close
₹45
Volume
3,000
As of
BSE · may be slightly delayed · 16:00 IST
Price history
No analyst calls on this stock in the last 90 days yet.
Explore by date range →Analyst opinions
Fundamentals
About KK Shah Hospitals Limited
KK Shah Hospitals Limited provides healthcare services in India. It provides services in the areas of general surgery, orthopaedics, obstetrics and gynecology, dental, general medicine, ambulance services, pediatrics, accident and emergency, ICU, physiotherapy, radiology, and ophthalmology services, as well as robotic knee replacement surgery. The company was formerly known as Jeevan Parv Healthcare Limited and changed its name to KK Shah Hospitals Limited in September 2022. KK Shah Hospitals Limited was founded in 1976 and is based in Ratlam, India.
Details
Sector
Healthcare
Industry
Medical Care Facilities
CEO
Dr. Amit Shah
Headquarters
Ratlam
Employees
77
Website
shahhospitalratlam.comExchange
View on BSE ↗Key stats
Market cap
₹30.64 Cr
EPS (TTM)
₹-0.91
Beta (1Y · daily vs NIFTY 50)
0.15
Shares float
19.50 L
Financial Performance
01 · Financials
FY23 growth needs FY22 filings, which the data source doesn't provide.
02 · Earnings Per Share (EPS)
03 · Dividend Profile
Growth compares completed fiscal-year dividend totals on the company's own calendar: April–March (Indian FY), taken from its reported period-ends. Payout ledger: Yahoo (no NSE corporate-actions ledger for this listing).
04 · Operating Efficiency (Growth Rates)
Balance-sheet-based · pre-FY23 not filed in verifiable form
05 · Capital Structure & Asset Utilization
Pre-FY23 not filed in verifiable form
Asset turnover needs a prior year of assets — omitted for the earliest available year.
06 · Asset Base Composition
Pre-FY23 not filed in verifiable form
07 · Debt Level & Coverage
Pre-FY23 not filed in verifiable form
08 · Profit & Loss
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹2.12 Cr | ₹6.88 Cr | ₹9.00 Cr | ₹9.43 Cr | |
| EBITDA | ₹38.91 L | ₹1.08 Cr | ₹68.67 L | ₹95.57 L |
| ₹21.81 L | ₹60.70 L | ₹-32.70 L | ₹-62.30 L | |
| Diluted EPS | ₹0.32 | ₹1.07 | ₹-0.48 | — |
Total expenses (as filed), Employee benefit expense, Other expenses, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
09 · Balance Sheet
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹5.61 Cr | ₹14.63 Cr | ₹15.98 Cr | ₹15.03 Cr | |
| ₹0 | ₹0 | ₹0 | ₹0 | |
| Stockholders' equity | ₹5.09 Cr | ₹14.09 Cr | ₹13.42 Cr | ₹12.79 Cr |
Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.
10 · Cash Flow Statement
Annual
| Line item | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| ₹54.83 L | ₹-58.22 L | ₹2.25 Cr | ₹68.86 L | |
| Investing cash flow | ₹-3.40 Cr | ₹-9.02 Cr | ₹-2.35 Cr | ₹-59.77 L |
| ₹4.87 Cr | ₹8.39 Cr | ₹-34.04 L | ₹0 | |
| Capital expenditure | ₹-1.39 Cr | ₹-98.18 L | ₹-6.92 Cr | ₹-6.59 Cr |
| End cash position | ₹2.02 Cr | ₹80.51 L | ₹36.92 L | ₹46.01 L |
Debt issued, Dividends paid have filed figures for only some of the years shown — the missing years are left blank rather than estimated.
Annual only — the data source has no quarterly cash-flow-statement coverage.
12 · Peer Comparison
Healthcare
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹4.48 L Cr | ₹1,846.4 | 37.1 | 5.37 | 13.7% | 0.06 | +11.9% | +12.3% |
| Divi's Laboratories Limited | ₹2.49 L Cr | ₹9,410.5 | 84.7 | 14.85 | 15.3% | 0.00 | +12.3% | +51.8% |
| Torrent Pharmaceuticals Limited | ₹1.84 L Cr | ₹4,970 | 77.5 | 21.95 | 25.8% | 1.79 | +21.5% | +36.9% |
| Apollo Hospitals Enterprise Limited | ₹1.28 L Cr | ₹8,835.5 | 61.5 | 13.52 | 20.5% | 0.90 | +15.7% | +14.2% |
| Lenskart Solutions Limited | ₹1.18 L Cr | ₹691.45 | 179.0 | 13.55 | 5.6% | 0.35 | +35.4% | — |
| Zydus Lifesciences Limited | ₹1.16 L Cr | ₹1,161 | 25.8 | 4.27 | 18.6% | 0.46 | +18.4% | +11.9% |
| Cipla Limited | ₹1.12 L Cr | ₹1,384.1 | 33.2 | 3.25 | 11.3% | 0.02 | +2.1% | -10.3% |
| Laurus Labs Limited | ₹1.09 L Cr | ₹2,006.5 | 99.3 | 20.57 | 16.8% | 0.48 | +22.0% | +122.0% |
| Max Healthcare Institute Limited | ₹1.02 L Cr | ₹1,066.6 | 70.4 | 9.50 | 13.4% | 0.32 | +19.0% | -8.0% |
| Manipal Health Enterprises Limited | ₹99,047.90 Cr | ₹746.1 | 152.1 | 11.75 | 7.8% | 1.53 | +18.0% | — |
| Dr. Reddy's Laboratories Limited | ₹98,709.15 Cr | ₹1,198.3 | 29.8 | 2.62 | 11.4% | 0.21 | +3.2% | -9.3% |
| KK Shah Hospitals Limited | ₹30.64 Cr | ₹45 | — | 2.39 | -4.9% | 0.00 | +4.8% | 0.0% |
Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.
Documents
Annual reports
Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.